Regulation of human flavin-containing monooxygenase 3 (FMO3) by D-element binding protein (DBP) and Yin Yang 1 (YY1)

被引：0
|
作者：
Klick, DE
Hines, RN
机构：
[1] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Pharmacol Toxicol, Milwaukee, WI 53226 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
402
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms:: linkage and effects on in vivo and in vitro FMO activities
    Park, CS
    Kang, JH
    Chung, WG
    Yi, HG
    Pie, JE
    Park, DK
    Hines, RN
    McCarver, DG
    Cha, YN
    PHARMACOGENETICS, 2002, 12 (01): : 77 - 80
  • [42] Tolerance to Acetaminophen Hepatotoxicity in the Mouse Model of Autoprotection Is Associated with Induction of Flavin-Containing Monooxygenase-3 (FMO3) in Hepatocytes
    Rudraiah, Swetha
    Rohrer, Philip R.
    Gurevich, Igor
    Goedken, Michael J.
    Rasmussen, Theodore
    Hines, Ronald N.
    Manautou, Jose E.
    TOXICOLOGICAL SCIENCES, 2014, 141 (01) : 263 - 277
  • [43] A series of simple detection systems for genetic variants of flavin-containing monooxygenase 3 (FMO3) with impaired function in Japanese subjects
    Shimizu, Makiko
    Mizugaki, Ami
    Koibuchi, Natsumi
    Sango, Haruna
    Uenuma, Yumi
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 41
  • [44] Flavin-Containing Monooxygenase 3 (FMO3) Is Critical for Dioxin-Induced Reorganization of the Gut Microbiome and Host Insulin Sensitivity
    Massey, William
    Osborn, Lucas J.
    Banerjee, Rakhee
    Horak, Anthony
    Fung, Kevin K.
    Orabi, Danny
    Chan, E. Ricky
    Sangwan, Naseer
    Wang, Zeneng
    Brown, J. Mark
    METABOLITES, 2022, 12 (04)
  • [45] Simple confirmation methods for rare but impaired variants of human flavin-containing monooxygenase 3 (FMO3) found in an updated genome resource databank
    Shimizu, Makiko
    Makiguchi, Miaki
    Yokota, Yuka
    Shimamura, Erika
    Matsuta, Moegi
    Nakamura, Yuria
    Harano, Mizuki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [46] Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway (vol 12, e0187294, 2017)
    El-Serafi, I
    Terelius, Y.
    Abedi-Valugerdi, M.
    Naughton, S.
    Saghafian, M.
    Moshfegh, A.
    PLOS ONE, 2017, 12 (12):
  • [47] Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure
    Zhou, Wangda
    Humphries, Helen
    Neuhoff, Sibylle
    Gardner, Iain
    Masson, Eric
    Al-Huniti, Nidal
    Zhou, Diansong
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (06) : 389 - 393
  • [48] A family study of compound variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found by urinary phenotyping for trimethylaminuria
    Shimizu, Makiko
    Yamamoto, Akane
    Makiguchi, Miaki
    Shimamura, Erika
    Yokota, Yuka
    Harano, Mizuki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 50
  • [49] Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants
    Koukouritaki, SB
    Poch, MT
    Cabacungan, ET
    McCarver, DG
    Hines, RN
    MOLECULAR PHARMACOLOGY, 2005, 68 (02) : 383 - 392
  • [50] Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome
    Dolphin, CT
    Janmohamed, A
    Smith, RL
    Shephard, EA
    Phillips, IR
    PHARMACOGENETICS, 2000, 10 (09): : 799 - 807
12345